Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gamera Bioscience was a biotechnology company specializing in the development of centrifugal microfluidic systems, most notably the "Lab-on-a-CD" (LabCD) platform. The technology utilized a disposable plastic disc to perform complex laboratory assays, using centrifugal force to move fluids through micro-channels for processing. This platform was designed to automate and miniaturize tasks in drug discovery, genomics, and clinical diagnostics, significantly reducing reagent consumption and processing time. Founded in 1996 and based in Medford, Massachusetts, the company established key partnerships with industry leaders like Amersham Pharmacia Biotech. In 1999, Gamera Bioscience was acquired by the Tecan Group, which integrated the LabCD technology into its portfolio of automated laboratory instruments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gamera Bioscience.